ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 174 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.61 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $106,487 | -43.5% | 5,197 | -45.2% | 0.00% | – |
| Q2 2023 | $188,387 | -1.7% | 9,481 | -15.2% | 0.00% | – |
| Q1 2023 | $191,548 | +6.9% | 11,182 | +22.2% | 0.00% | – |
| Q4 2022 | $179,144 | +64.4% | 9,154 | +34.2% | 0.00% | – |
| Q3 2022 | $109,000 | -97.2% | 6,821 | -97.6% | 0.00% | -100.0% |
| Q2 2022 | $3,896,000 | -42.6% | 283,124 | -33.8% | 0.01% | -26.7% |
| Q1 2022 | $6,786,000 | +1539.1% | 427,851 | +4481.8% | 0.02% | +1400.0% |
| Q1 2021 | $414,000 | -53.2% | 9,338 | -42.1% | 0.00% | -50.0% |
| Q4 2020 | $885,000 | -80.0% | 16,129 | -91.7% | 0.00% | -80.0% |
| Q3 2020 | $4,426,000 | +86.0% | 193,626 | +13.5% | 0.01% | +42.9% |
| Q1 2020 | $2,379,000 | +149.9% | 170,545 | +307.9% | 0.01% | +250.0% |
| Q4 2019 | $952,000 | -84.1% | 41,811 | -89.6% | 0.00% | -87.5% |
| Q4 2018 | $5,979,000 | -56.9% | 403,452 | -28.4% | 0.02% | -50.0% |
| Q3 2018 | $13,873,000 | – | 563,474 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $11,354,000 | 10.44% |
| RTW INVESTMENTS, LP | 15,802,802 | $250,632,000 | 5.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 63,000 | $17,884,000 | 4.03% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,077,000 | 4.02% |
| Prosight Management, LP | 203,268 | $3,224,000 | 2.08% |
| COWEN AND COMPANY, LLC | 1,000,000 | $15,860,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,252,000 | 1.20% |
| Cormorant Asset Management, LP | 868,550 | $13,775,000 | 1.06% |
| Amitell Capital Pte Ltd | 97,331 | $1,544,000 | 0.90% |
| SECTORAL ASSET MANAGEMENT INC | 303,975 | $4,821,000 | 0.86% |